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Abstract
Objective
A growing body of preclinical and clinical literature suggests that brain-gut-microbiota inter-
actions play an important role in human health and disease, including hedonic food intake
and obesity. We performed a tripartite network analysis based on graph theory to test the
hypothesis that microbiota-derived fecal metabolites are associated with connectivity of key
regions of the brain’s extended reward network and clinical measures related to obesity.
Methods
DTI and resting state fMRI imaging was obtained from 63 healthy subjects with and without
elevated body mass index (BMI) (29 males and 34 females). Subjects submitted fecal sam-
ples, completed questionnaires to assess anxiety and food addiction, and BMI was
recorded.
Results
The study results demonstrate associations between fecal microbiota-derived indole metab-
olites (indole, indoleacetic acid, and skatole) with measures of functional and anatomical
connectivity of the amygdala, nucleus accumbens, and anterior insula, in addition to BMI,
food addiction scores (YFAS) and anxiety symptom scores (HAD Anxiety).
Conclusions
The findings support the hypothesis that gut microbiota-derived indole metabolites may
influence hedonic food intake and obesity by acting on the extended reward network, specif-
ically the amygdala-nucleus accumbens circuit and the amygdala-anterior insula circuit.
These cross sectional, data-driven results provide valuable information for future mechanis-
tic studies.
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Introduction
A growing body of preclinical literature has demonstrated bidirectional signaling between the
gut microbiome and the brain, mediated via neural, metabolic, endocrine, and immune-
related signaling mechanisms [1, 2]. As the composition of the human gut microbiome is
dependent on host diet, there is likely strong selective pressure on the microbiota to modulate
food intake and eating habits [3]. In support of this concept are studies on animal models of
obesity that demonstrate the gut microbiota’s influence on ingestive behavior [3, 4].
Past studies have shown associations between increased weight and alterations in brain
activity and connectivity, underscoring the possible role of the brain in the pathophysiology of
obesity [5–9]. Brain networks involving the nucleus accumbens (NAcc), amygdala and the
anterior insula (aINS) are among the most extensively studied brain regions with respect to
gut-brain signaling involved in the regulation of non-homeostatic food intake [10]. These
regions have been shown to play a role in assessing the hedonic value of food [11]. The amyg-
dala integrates affective information with cortical sensory inputs and contains glutamatergic
projections to the NAcc [12, 13]. This amygdala-NAcc circuit is important in the promotion of
motivational behavioral responses and has been implicated in addiction disorders, and in the
regulation of hedonic eating habits (“food addiction”) [12–14]. The aINS plays a role in the
experience of emotional feelings and conscious urgings and cravings, in addition to its role as
an association cortex, integrating input from subcortical, limbic and executive control brain
networks [15, 16].
In addition to identifying anatomical and functional alterations in specific brain regions,
more recent efforts have focused on identifying alterations in brain network properties [17].
Brain connectivity can be assessed using complex network analysis via graph theory. Within
this framework, brain regions are characterized by measures that quantify their contribution
to the functional and anatomical integrity and information flow in the whole brain network
[18–21].
Although the exact signaling mechanisms underlying the communication within the brain-
gut-microbiome (BGM) axis remain incompletely understood, tryptophan (TRP) metabolites
have been implicated as important signaling molecules in this system [22]. Perhaps the most
extensively studied TRP metabolite is serotonin (5-HT), with diverse roles in both the gastro-
intestinal (GI) tract (i.e. secretion and absorption, intestinal transit) and the central nervous
system (CNS) (i.e. mood, pain modulation, behavior, cognitive function) [23]. The close prox-
imity of the gut microbiota to 5-HT-producing enterochromaffin cells (ECCs) strongly sug-
gests that the gut microbiota may modulate the serotonergic system. In turn, the intimate,
synapse-like contact of vagal afferent nerve terminals to the basolateral side of ECCs estab-
lishes a pathway by which microbial signals can activate vagal afferents via 5-HT release. In a
mouse model, metabolites derived from spore-forming bacteria of the human gut microbiota
have been shown to play a prominent role in the regulation of ECC 5-HT synthesis and release
[24]. TRP also acts as a precursor to the kynurenine (KYN) family of molecules. Quantitatively,
the KYN pathway is the most important pathway for TRP metabolism, outside of protein syn-
thesis, as under normal conditions it is responsible for more than 90% of TRP catabolism [25].
Though the KYN pathway represents the major TRP degradation pathway by host cells,
most undigested dietary TRP in the gut lumen is converted by gut microbes to indole. This is
mediated by the exclusively microbial tryptophanase enzyme, which catalyzes the conversion
of TRP to indole, pyruvate, and ammonia [25, 26]. Indole is a common component of human
feces, often detectable at concentrations up to 1,100 μM [27]. Indole and indole-derived
metabolites have many functions within the BGM axis, including the modulation of KYN
Tryptophan metabolites and central reward system
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synthesis and incretin secretion, strengthening of the mucosal intestinal barrier, and attenua-
tion of CNS inflammation–all of which have been shown to be disrupted in obesity [25, 27–
32].
By studying anatomical and functional connectivity measures and fecal gut microbial
metabolites in healthy subjects with and without elevated body mass index (BMI), we aimed to
test the hypothesis that indole metabolites are associated with connectivity of key regions of
the brain’s reward network. We determined the relationship between gut-derived indole
metabolites with local connectivity of regions of the extended reward network (amygdala,
aINS and NAcc) and clinical measures related to hedonic food intake and body weight. Even
though these results do not prove causation, and need to be validated in a larger sample, they
provide support for an association between gut-derived microbial metabolites and aspects of
brain structure and function, which may play a role in hedonic food intake and obesity. These
cross sectional data-driven results provide valuable information for future mechanistic studies.
Materials and methods
Subjects
Stool samples were collected at the G. Oppenheimer Center for Neurobiology of Stress and
Resilience at the University of California, Los Angeles (UCLA) from 63 right-handed healthy
subjects (29 males, 34 females), who also underwent multimodal brain imaging studies. Exclu-
sionary criteria included (1) serious medical conditions or taking medications which could
compromise interpretation of the brain imaging; (2) current major psychiatric diagnoses or
use of psychotropic medications in the past 6 months; (3) use of antibiotics in the past 3
months and (4) excessive physical exercise (e.g., marathon runners).
Written informed consent was obtained from all subjects, and all subjects were compen-
sated for participating in the study. The study was approved by the UCLA Institutional Review
Board and was conducted in full accordance with the institutional guidelines regulating
human subjects research.
Questionnaires
The Hospital Anxiety and Depression (HAD) Scale [33] was obtained to assess anxiety and
depression symptoms. Scores 0–7 define the normal range, 8–10 define the borderline range,
and 11–21 define the abnormal range [33]. As only two subjects received scores outside of the
normal range for the depression subscale, only the anxiety subscale was included in our analy-
sis (see results). All subjects completed the HAD scale. Subjects filled out the Yale Food Addic-
tion Scale (YFAS) questionnaire, a 25-item scale developed to measure food addiction. This
scale is based upon the substance dependence criteria found in the DSM-5 (e.g., tolerance
[marked increase in amount; marked decrease in effect], withdrawal [agitation, anxiety, physi-
cal symptoms], loss of control [eating to the point of feeling physical ill]) [34]. The YFAS has
displayed a good internal reliability (Kuder–Richardson α = .86) [34]. Only 42 subjects com-
pleted the YFAS, as it was not available at the time of recruitment of all subjects. BMI was
recorded for all subjects.
Fecal metabolomics
Fecal samples were stored at -80˚C and shipped to Metabolon for processing and analysis as a
single batch on their global metabolomics and bioinformatics platform [35]. Data was curated
by mass spectrometry using specialized software as previously described [35]. Metabolites of
interest were restricted to indole, 3-methylindole (skatole), and indoleacetic acid (IAA).
Tryptophan metabolites and central reward system
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Magnetic resonance imaging
Structural MRI. High resolution T1-weighted images were acquired on a Siemens Allegra
3 Tesla scanner, repetition time = 2200 ms, echo time = 2.85s, inversion time = 750 ms, flip
angle = 20 degrees, Field of view = 220 × 220 mm, resolution = 256 × 256, slices per vol-
ume = 176, slice thickness = 1 mm, voxel size = 0.86 × 0.86 × 1 mm.
Functional MRI. Resting-state scans between 8m6s and 10m6s in length were acquired
with an echo planar sequence with the following parameters: echo time = 28 ms, repetition
time = 2000 ms, scan duration = 8m6s–10 m6s, flip angle = 77˚, field of view = 220 mm,
slices = 40 and slice thickness = 4.0 mm, and slices were obtained with whole-brain coverage.
Diffusion-weighted MRI. Diffusion-weighted magnetic resonance imaging was acquired
according to two comparable acquisition protocols, in either 61 or 64 noncolinear directions
with b = 1000 s mm−2, with 8 or 1 b = 0 s mm−2 images respectively, TR = 9500 ms, TE = 88ms
and field of view = 256 mm with an acquisition matrix of 128x128, and a slice thickness of 2
mm to produce 2 × 2 × 2 mm3 isotropic voxels.
Quality control of MRI data
Preprocessing for quality control involved bias field correction, coregistration, motion correc-
tion, spatial normalization, tissue segmentation, Fourier transformation for frequency distri-
bution, and specific quantitative checks for DTI images (apparent diffusion coefficient and
fractional anisotropy [FA]). Structural images were included based on compliance with acqui-
sition protocol, full brain coverage, minimal motion (Gibbs ringing), absence of flow/zipper,
and minor atrophy/vascular degeneration. Functional images were included based on compli-
ance with acquisition protocol, full brain coverage, motion estimate of<½ voxel size between
adjacent time points, low standard deviation across time series for all voxels, ghosting in cere-
brum, minimal physiological noise (>0.2Hz in frequency spectrum), and few to no outlier
voxels, mean intensity shifts, or K-space “spikes.” Preprocessing for diffusion-weighted imag-
ing included visually checking for artifacts and motion on the raw diffusion weighted and b0
images, visual assessment of FA and mean diffusitivity (MD) map quality, as well checking for
physiologically feasible FA and MD values (FA of 0–0.1 and MD of 3–4 μm2/ms in ventricles,
and FA of 0.6–0.9 and MD of 0.6–0.9 μm2/ms in splenium of corpus callosum). Maximum rel-
ative motion thresholds for translation and rotation for each direction (x, y, and z) were set at
2mm and 2˚, respectively. No subjects presented with serious adverse imaging artifacts and no
subjects exceeded motion thresholds: the highest maximum relative translation for any subject
was 1.37mm, and the highest maximum relative rotation was 1.59˚. Only one DTI scan did not
meet quality control criteria and was excluded from analysis. All other DTI and resting state
scans met quality control criteria and were included in the analysis.
Structural image parcellation
T1-image segmentation and regional parcellation were conducted using FreeSurfer v.5.3.0[36–
38] following the nomenclature described in the Destrieux and Harvard-Oxford subcortical
atlas [39, 40]. For each cerebral hemisphere, a set of 74 cortical structures were labeled in addi-
tion to 7 subcortical structures and to the cerebellum. One additional midline structure (the
brain stem) was also included, for a complete set of 165 parcellations for the entire brain.
Functional brain network construction
The parcellation and the functional connectivity results were combined to produce a 165x165
weighted, unidirected connectivity matrix. Resting-state image preprocessing was performed
Tryptophan metabolites and central reward system
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using the SPM8 software (Wellcome Department of Cognitive Neurology, London, UK).
Images were transformed from DICOM into NIfTI, slice-time corrected, co-registered with
the high-resolution structural images, spatially normalized to the MNI space, and resampled
to a voxel size of 2 X 2 X 2 mm. Normalized functional images were further preprocessed and
analyzed using the SPM-based CONN toolbox version 13 (www.nitrc.org/projects/conn). The
resting-state images were filtered using a band-pass filter (0.008/s<f<0.08/s) to reduce the
low- and high-frequency noises. A component based noise-correction method, CompCor,[41]
was applied to remove nuisances for better sensitivity and specificity of the analysis. Six motion
realignment parameters and confounds for white matter and CSF were removed using regres-
sion. The connectivity between the 165 brain regions was indexed by a matrix of Fisher z trans-
form correlation coefficients reflecting the association between average temporal BOLD time
series signals across all voxels in each brain region. Functional connections were retained at
z>.3 and all other values were set to 0. The magnitude of the z-score represents the weights in
the functional network.
Anatomical network construction
Regional parcellation and tractography results were combined to produce a weighted, unidir-
ected connectivity matrix. White matter connectivity for each subject was estimated between
the 165 brain regions using DTI fiber tractography,[42] performed via the Fiber Assignment
by Continuous Tracking (FACT) algorithm[43] using TrackVis (http://trackvis.org). The final
estimate of white matter connectivity between each of the brain regions was determined based
on the number of fiber tracts intersecting each region. Weights of the connections were then
expressed as the absolute fiber count divided by the individual volumes of the two intercon-
nected regions [20].
Regions of interest
Key regions of the extended reward that have been extensively studied with respect to gut-
brain signaling involved in the regulation of non-homeostatic food intake were included [10].
Regions of interest were restricted to the NAcc, amygdala, and aINS (including short insular
gyrus, anterior segment of the circular sulcus of the insula, horizontal ramus of the anterior
segment of the lateral sulcus, and vertical ramus of the anterior segment of the lateral sulcus)
(Fig 1).
Computing network metrics
The Graph Theoretic GLM tool (www.nitrc.org/projects/metalab_gtg)[44] and in-house
matlab scripts were used to calculate and analyze the brain network properties and organiza-
tion from the subject-specific functional brain networks for the brain regions of interest.
Regions with high centrality are highly influential, communicate with many other regions,
facilitate functional integration, and play a key role in network resilience to insult [21]. Two
indices of centrality were computed: 1) Degree Strength reflects the number of other regions a
brain region interacts with functionally (local prominence) and 2) Betweenness centrality,
reflecting the ability of a region to influence information flow (signaling) between two other
regions.
Statistical analysis
Tripartite network analysis was performed to integrate information from three data sets: 1)
Stool derived indole metabolites (indole, skatole, and IAA), 2) clinical data (BMI, YFAS, HAD
Tryptophan metabolites and central reward system
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Anxiety) and 3) the functional and anatomical network metrics characterizing regions of inter-
est (amygdala, NAcc, and aINS [short insular gyrus, anterior segment of the circular sulcus of
the insula, horizontal ramus of the anterior segment of the lateral sulcus, and vertical ramus of
the anterior segment of the lateral sulcus]). The interaction between the phenome (clinical
measures), microbiome (stool-derived indole metabolites) and connectome (brain connectiv-
ity) was determined by computing Spearman correlations between different data types con-
trolling for age and sex in Matlab version R2015b. The unweighted force-directed layout in
Fig 1. Regions of interest and associated regions. Fig 1 displays regions of interest (nucleus accumbens [orange],
amygdala [green], and anterior insula [blue; includes short insular gyrus, anterior segment of the circular sulcus of the
insula, horizontal ramus of the anterior segment of the lateral sulcus, and vertical ramus of the anterior segment of the
lateral sulcus]) and the brain stem (pink).
https://doi.org/10.1371/journal.pone.0201772.g001
Tryptophan metabolites and central reward system
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Cytoscape v. 3.5.1 was used to visualize and construct brain, symptom, and gut-derived metab-
olite interaction networks thresholded at q< .05 corrected p value using a false discovery rate
of 5%. We present the networks based on selecting the metabolites and their first neighbors as
nodes and all adjacent edges. The results are described in terms of direct (correlations with
metabolites) and indirect effects (clinical symptoms and functional and anatomical network
metrics that are a part of the interaction network but not directly correlated with the
metabolite).
Results
Clinical and behavioral characteristics
Patient ages ranged from 18 to 60 (mean: 29.42, SD: 10.76). BMI ranged from 17.90 to 37.34
(mean: 25.82, SD: 4.93). Subjects with high BMI (BMI 25: mean = 30.00, SD = 3.31,
range = 25.11–37.34) consisted of 17 males (mean = 29.26, SD = 3.33, range = 25.11–37.34)
and 14 females (mean = 30.90, SD = 3.18, range = 25.52–37.09). Subjects with normal BMI
(BMI< 25: mean BMI = 21.77, SD = 1.90, range = 17.90–24.53) consisted of 12 males
(mean = 22.21, SD = 1.88, range = 17.90–24.10) and 20 females (mean = 21.50, SD = 1.91,
range = 18.80–24.53). Scores on the YFAS ranged from 0 to 7 (mean: 1.24, SD: 1.25). HAD
Anxiety scores ranged from 0 to 13 (mean: 4.25, SD: 3.41; normal: 50 subjects, borderline: 10
subjects, abnormal: 3 subjects). HAD Depression scores ranged from 0 to 11 (mean: 1.87, SD:
2.23; normal: 61 subjects, borderline: 1 subject, abnormal: 1 subject).
Association of clinical parameters with indole metabolites
The indole metabolite skatole positively correlated with YFAS scores. Although not surviving
FDR correction, indole positively correlated with BMI and negatively with anxiety scores. (For
details, see Tables 1 and 2)
Amygdala-NAcc circuit
Indole, skatole and IAA showed large positive correlations with functional connectivity of the
NAcc. Skatole showed a positive association with measures of anatomical connectivity of the
amygdala, whereas IAA associated positively with functional connectivity of the amygdala.
YFAS scores and HAD Anxiety scores showed positive associations with functional connectiv-
ity of the NAcc. (see Table 1)
Amygdala-aINS circuit
Anatomical connectivity of the amygdala showed a positive correlation with skatole, while
functional connectivity of this brain regions showed a positive association with IAA. Anatomi-
cal connectivity of a region within the aINS, showed a positive association with indole, while
functional connectivity of the same brain region showed a positive association with YFAS
scores. (see Table 2)
Fig 2 displays the tripartite association network between indole metabolites, clinical and
behavioral measures, and connectivity of the amygdala-aINS circuit and the amygdala-NAcc
circuit. All three metabolites showed indirect association with YFAS through functional con-
nectivity of the right NAcc. Skatole also showed an indirect association with anxiety through
functional connectivity of the left NAcc, in addition to indirect associations to YFAS through
functional connectivity of the left NAcc and a region within the aINS.
Tryptophan metabolites and central reward system
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Discussion
This study demonstrates associations between fecal indole metabolites, measures of functional
and anatomical connectivity of key regions of the extended reward network, in addition to
BMI, food addiction scores (YFAS) and anxiety symptom scores (HAD Anxiety) in healthy
individuals with varying BMIs. These results are consistent with the literature on the role of
indole metabolites in mammalian physiology and support the hypothesis that gut microbiota-
derived indole metabolites may influence food intake by acting on the extended reward net-
work, specifically the amygdala-NAcc circuit and the amygdala-aINS circuit. Even though
these cross sectional findings were obtained in a relatively small sample cohort, to our knowl-
edge, this is the first report demonstrating an association between microbial-derived stool
metabolites of the indole family with connectivity of brain regions of the extended reward net-
work in healthy humans.
Association of indole metabolites with connectivity of amygdala and
nucleus accumbens
Our results show direct associations between the functional connectivity of the amygdala with
IAA, and between anatomical connectivity of this region with skatole, with all metabolites
showing a strong association with functional connectivity of the NAcc. Skatole showed a direct
positive association with YFAS scores, while IAA showed an indirect positive association with
skatole through functional connectivity of the NAcc. Although not statistically significant fol-
lowing FDR correction, indole showed a direct positive association with BMI and an indirect
positive association with YFAS through functional connectivity of the NAcc. One likely mech-
anism by which indoles could influence this part of the reward circuit may be through
Table 1. Amygdala-nucleus accumbens associations.
Metabolite Functional Connectivity r p q df
Indole B_R_NAcc 0.59608 < 0.001 < 0.001 62
IAA S_R_Amg 0.37640 0.003 0.011 62
Indole S_R_NAcc 0.36637 0.004 0.011 62
IAA S_R_NAcc 0.33201 0.009 0.018 62
Skatole S_R_NAcc 0.31022 0.015 0.022 62
Skatole S_L_NAcc 0.33839 0.008 0.046 62
Clinical/Behavioral Measure Functional Connectivity r p q df
YFAS S_L_NAcc 0.59632 < 0.001 < 0.001 41
ANX S_L_NAcc 0.29999 0.019 0.056 62
YFAS S_R_NAcc 0.36944 0.019 0.114 62
Metabolite Anatomical Connectivity r p q df
Skatole S_L_Amg 0.55362 < 0.001 < 0.001 61
Metabolite Clinical/Behavioral Measure r p q df
Skatole YFAS 0.48043 0.002 0.017 41
Indole ANX -0.28741 0.025 0.086 62
Indole BMI 0.28036 0.029 0.090 62
This table shows all significant associations prior to FDR correction with r, p, FDR-corrected q values, and df (degrees of freedom) for the amygdala-nucleus accumbens
circuit.
Abbreviations: ANX, Hospital anxiety and depression (HAD) scale anxiety score; B_R_NAcc, Betweenness centrality of the right nucleus accumbens; BMI, Body mass
index; IAA, Indoleacetic acid; S_L_Amg, Degree strength of the left amygdala; S_L_NAcc, Degree strength of the left nucleus accumbens; S_R_Amg, Degree strength of
the right amygdala; S_R_NAcc, Degree strength of the right nucleus accumbens; YFAS, Yale food addiction scale score.
https://doi.org/10.1371/journal.pone.0201772.t001
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interactions with the enteroendocrine L-cells of the gut and GLP-1. The peptide hormone
GLP-1 and GLP-1 receptor agonists have been studied within the context of obesity, as they
are associated with better glycemic control, reduction of body weight and increased satiety
[45]. Indole can modulate GLP-1 secretion in mouse colonic L-cells by influencing voltage-
gated potassium channels and mitochondrial NADH dehydrogenase [29]. Exposure to indole
over short periods of time resulted in increased secretion of GLP-1, whereas longer exposure
led to decreased secretion [29]. As most GLP-1 is rapidly inactivated by dipeptidyl peptidase 4
prior to leaving the gut, it is likely that GLP-1 acts locally on vagal afferent nerve terminals,
and signals via vagal afferents to the nucleus tractus solitarius (NTS) and to brain circuits
involved in the regulation of ingestive behavior [45]. This is consistent with a recent human
study, which showed that the GLP-1 agonist Exenatide can impact appetite control by modu-
lating the functional connectivity of reward regions associated with the NTS [46]. An alterna-
tive hypothesis posits that vagal afferent modulation of the amygdala-NAcc circuit may occur
through modulation of the gut serotonergic system. Since it has been shown that metabolites
from spore-forming bacteria of the gut microbiota regulate ECC 5-HT synthesis and release,
an indole derivative that affects this microbial community may influence the gut serotonergic
system [24]. The established role of indoles as valuable intercellular signaling molecules in
Table 2. Amygdala-anterior insula associations.
Metabolite Functional Connectivity r p q df
IAA S_R_Amg 0.37639 0.003 0.042 62
Skatole B_L_ALSVerp (aINS) 0.33542 0.008 0.123 62
IAA S_R_ALSVerp (aINS) 0.27091 0.035 0.206 62
IAA S_L_ALSHorp (aINS) 0.26168 0.042 0.625 62
Clinical/Behavioral Measure Functional Connectivity r p q df
YFAS B_L_ALSVerp (aINS) 0.53843 < 0.001 0.005 41
BMI B_R_ShoInG (aINS) 0.29197 0.022 0.336 62
Metabolite Anatomical Connectivity r p q df
Skatole S_L_Amg 0.55362 < 0.001 < 0.001 61
Indole B_L_ALSHorp (aINS) 0.49712 < 0.001 < 0.001 61
Skatole S_R_ALSHorp (aINS) 0.31036 0.016 0.237 61
Skatole S_R_ALSVerp (aINS) 0.26351 0.042 0.314 61
Skatole B_R_ALSHorp (aINS) 0.25465 < 0.050 0.503 61
Clinical/Behavioral Measure Anatomical Connectivity r p q df
BMI B_L_ShoInG (aINS) 0.30157 0.019 0.288 61
Metabolite Clinical/Behavioral Measure r p q df
Skatole YFAS 0.48043 0.002 0.017 41
Indole ANX -0.28741 0.025 0.086 62
Indole BMI 0.28036 0.029 0.090 62
This table shows all significant associations prior to FDR correction with r, p, FDR-corrected q values, and df (degrees of freedom) for the amygdala-anterior insula
circuit.
Abbreviations: ANX, Hospital anxiety and depression (HAD) scale anxiety score; B_L_ALSHorp, Betweenness centrality of the left horizontal ramus of the anterior
segment of the lateral sulcus (aINS); B_L_ALSVerp, Betweenness centrality of the left vertical ramus of the anterior segment of the lateral sulcus (aINS); B_L_ShoInG,
Betweenness centrality of the left short insular gyrus (aINS); B_R_ALSHorp, Betweenness centrality of the right horizontal ramus of the anterior segment of the lateral
sulcus (aINS); B_R_ShoInG, Betweenness centrality of the right short insular gyrus (aINS); BMI, Body mass index; IAA, Indoleacetic acid; S_L_ALSHorp, Degree
strength of the left horizontal ramus of the anterior segment of the lateral sulcus (aINS); S_L_Amg, Degree strength of the left amygdala; S_R_ALSHorp, Degree
strength of the right horizontal ramus of the anterior segment of the lateral sulcus (aINS); S_R_ALSVerp, Degree strength of the right vertical ramus of the anterior
segment of the lateral sulcus (aINS); S_R_Amg, Degree strength of the right amygdala; YFAS, Yale food addiction scale score.
https://doi.org/10.1371/journal.pone.0201772.t002
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microbial communities, with examples of indole signaling among spore-forming bacteria, fur-
ther supports this mechanism [47]. As 5-HT is intimately involved in vagal signaling along the
gut-brain axis, it is likely that vagal afferents would be responsible for communicating indole-
mediated modulation of the gut serotonergic system to central reward regions [48].
Association of indole metabolites with connectivity of amygdala and aINS
We found an association between the anatomical connectivity of the aINS with indole levels in
the stool, and of the amygdala with fecal skatole levels. In addition, the functional connectivity
of the amygdala was associated with fecal IAA levels. Signaling of gut microbiota to the amyg-
dala-aINS circuit may act directly through the amygdala by modulating CNS 5-HT synthesis;
one mechanism may involve the aryl hydrocarbon receptor (AhR). Many studies on the effects
of indoles on mammalian physiology have focused on their role as AhR ligands. When acti-
vated, AhR can function as a transcription factor that regulates the rate limiting enzymes in
TRP metabolism along the KYN pathway [49]. Increases in systemic KYN levels can limit
peripheral TRP bioavailablity for CNS 5-HT synthesis; KYN competes with TRP to cross the
blood-brain barrier (BBB) through the Large Neutral Amino Acid Transporter LAT1, an
Fig 2. Tripartite association network. Fig 2 displays the tripartite association network between indole metabolites, clinical and behavioral measures, and functional and
anatomical connectivity of the amygdala-NAcc circuit and the amygdala-aINS circuit. All significant (p< .05) associations are included in this visualization. Functional
brain connectivity of regions of interest is presented with the region of interest noted in a larger font, with the connectivity measure and lateralization indicated below in
the form X_Y, where X indicates a connectivity measure (B, Betweenness centrality; S, Degree strength) and Y indicates lateralization (L, Left; R, Right). Abbreviations:
aINS, anterior insula; ALSHorp, horizontal ramus of the anterior segment of the lateral sulcus (aINS); ALSVerp, vertical ramus of the anterior segment of the lateral
sulcus (aINS); Amg, amygdala; ANX, Hospital anxiety and depression (HAD) scale anxiety score; BMI, Body mass index; IAA, Indoleacetic acid; NAcc, nucleus
accumbens; ShoInG, short insular gyrus (aINS); YFAS, Yale food addiction scale score.
https://doi.org/10.1371/journal.pone.0201772.g002
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important point considering TRP uptake is the rate-limiting step in CNS 5-HT synthesis [50].
The consequences of reduced CNS 5-HT have been interrogated through acute TRP depletion
(ATD) studies, which generally show that ATD negatively influences mood and feeding behav-
ior as well as visceral sensitivity and abdominal symptoms [51, 52]. Considering the extensive
serotonergic innervation of the amygdala and its connections to the INS, modulation of CNS
TRP metabolism via indole-activated AhR may explain the association between indoles and
the amygdala-aINS circuit and the positive association between skatole and food addiction
scores [53].
Indoles may also act on the amygdala-aINS circuit by modulating aINS-mediated gustatory
processing. One mechanism that allows the GI tract to constantly sample the gut lumen is
through taste receptors expressed on ECCs and L-cells [54, 55]. Considering the established
relationship between indole and L-cells, and the proposed relationship between indoles and
ECCs, the gut microbiota may represent an extension of this luminal gustatory sensing mecha-
nism. As an example, glucose has been shown to inhibit indole biosynthesis via catabolite
repression of the tryptophanase enzyme, whereas TRP has been shown to induce the trypto-
phanase enzyme [26, 56]. The responsiveness of tryptophanase to the luminal environment
underscores the dynamic nature of this indole-aINS gustatory association suggested by our
data.
Association of indole metabolites with clinical and behavioral measures
Fecal skatole levels showed a positive association with food addiction scores; although not sig-
nificant following FDR correction, fecal indole levels positively associated with BMI and nega-
tively with anxiety scores. In contrast, IAA showed no direct associations with any clinical and
behavioral measures. It is interesting to note that IAA is the only metabolite investigated that
acts as a true AhR agonist, while both indole and skatole act as weak AhR agonists or partial
antagonists [57, 58]. Considering the diversity of AhR ligands that extends even past the indole
family of molecules, elevated concentrations of indole and skatole would interfere with the
binding of potentially higher affinity ligands to AhR [59]. The balance of indole and skatole to
IAA or to other AhR agonists may play an important role in the activity of AhR and subse-
quent downstream consequences [57], [60], [61]. Although future work is necessary to exam-
ine the importance of AhR on the gut-brain axis, our results suggest that indoles with partial-
antagonistic properties may be more clinically relevant than indoles with pure agonist proper-
ties with respect to the AhR.
Limitations
As we were interested in gut-microbiota derived indole metabolites, our study only examined
fecal samples and did not address possible direct actions of indole on the CNS through circum-
ventricular organs or by crossing the blood brain barrier. Because indoles are prone to exten-
sive modification through the CYP450 system, fecal samples are likely a more accurate
representation of the GI metabolomic profile [62]. Although there was a fair distribution and
range of BMIs among study participants, our study consisted primarily of subjects with BMIs
greater than 18.5. Additionally, less than a third of subjects did not complete the YFAS survey,
as it was not available at the time of their recruitment. Due to the limited sample size, we did
not explore sex-differences in this study. Future studies with a larger sample size, and perhaps
a more heterogeneous subject population with respect to BMI and YFAS scores would need to
be conducted to validate our results. Future studies should focus on identifying associations of
metabolites with brainstem regions, in particular the NTS in the analysis, possibly by using tai-
lored 3T brainstem acquisition protocols and ultra high field MRI (T7 or higher) [63–65].
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Although the associations presented in this study are consistent with conclusions from studies
that utilized animal models or in vitro approaches, no causative relationships can be implied
from an association study.
Summary and conclusions
To our knowledge, this is the first study demonstrating an association between microbial-
derived stool metabolites with connectivity of brain regions of the extended reward network in
healthy human subjects with varying BMI and food cravings. It is likely that a combination of
some or all of the proposed mechanisms plays a role in these associations. The inducible and
repressible nature of the tryptophanase enzyme, combined with the varying binding affinities
of different indoles to AhR underscore the importance of metabolic homeostasis of micro-
biota-derived metabolites and provides further evidence for the dynamic nature of the BGM
axis. This exploratory study provides valuable information for future mechanistic studies.
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